Sunday, December 21, 2025
ADVT 
International

Cap reached for H-2B visas for second half of FY 2023

Darpan News Desk IANS, 03 Mar, 2023 01:09 PM
  • Cap reached for H-2B visas for second half of FY 2023

New York, March 3 (IANS) The US has received a sufficient number of applications to meet the congressionally-mandated H-2B cap for the second half of fiscal year 2023, the country's federal agency for immigration services announced.

The US Citizenship and Immigration Services (USCIS) said February 27 was the final receipt date for new cap-subject H-2B worker petitions requesting an employment start date on or after April 1 and before October 1.

Currently, the congressionally-mandated cap for H-2B visa is set at 66,000 per fiscal year, with 33,000 for workers who begin employment in the first half of the fiscal year (October 1-March 31) and 33,000 for workers who begin employment in the second half of the fiscal year (April 1-September 30).

The agency also announced the filing dates for the supplemental H-2B visas for FY 2023, made available under the supplemental visa temporary final rule.Under this rule, the USCIS began accepting H-2B petitions increasing the cap by up to 64,716 additional H-2B non-immigrant visas for FY-2023.

These supplemental H-2B visas are for US employers seeking to petition for additional workers at certain periods of the fiscal year before September 15.

They are available only to US businesses that are suffering irreparable harm or will suffer impending irreparable harm without the ability to employ all the H-2B workers requested in their petition, the USCIS said.

The agency further said that it will continue to accept H-2B petitions that are exempt from the congressionally mandated cap, which includes current holders of this visa in the US who wish to extend their stay and, if applicable, change the terms of their employment or change their employers.

Others who are exempt include, fish roe processors, fish roe technicians and/or supervisors of fish roe processing; and workers performing labor or services in the Commonwealth of Northern Mariana Islands and/or Guam (until December 31, 2029).

The H-2B visas are issued for seasonal/temporary jobs which allow employers to hire skilled or unskilled workers to fulfil the shortage of workers in the US.

The employer must obtain a Department of Labor certification before the visa application can be initiated.

MORE International ARTICLES

White House on U.S. vaccine supply: America first

White House on U.S. vaccine supply: America first
That's despite the challenges faced by other countries, including Canada, in procuring vaccine doses from outside the United States.

White House on U.S. vaccine supply: America first

Attacks on older Asians stoke fear as Lunar New Year begins

Attacks on older Asians stoke fear as Lunar New Year begins
City officials also have visited Chinatowns in San Francisco and Oakland this week to address residents' safety concerns and condemn the violence.

Attacks on older Asians stoke fear as Lunar New Year begins

UN: 'Concerning news' vaccines may not work against variants

UN: 'Concerning news' vaccines may not work against variants
Tedros added that WHO expected to make a decision “in the next few days” on whether it would recommend an emergency use listing for the AstraZeneca vaccine.

UN: 'Concerning news' vaccines may not work against variants

Britain to test mixing and matching of COVID-19 vaccines

Britain to test mixing and matching of COVID-19 vaccines
The vaccines being rolled out now require two doses, and people are supposed to get two shots of the same kind, weeks apart.

Britain to test mixing and matching of COVID-19 vaccines

In U.S., Europe, hope about future health crises

In U.S., Europe, hope about future health crises
The Pew Research Center poll out today finds optimism for the future among a majority of 4,000 respondents in the U.S., the United Kingdom, France and Germany.

In U.S., Europe, hope about future health crises

Don't sell single-shot vaccine short, Fauci says

Don't sell single-shot vaccine short, Fauci says
Dr. Anthony Fauci says Johnson and Johnson's vaccine has virtues beyond an efficacy rate that lags that of its predecessors.

Don't sell single-shot vaccine short, Fauci says